For innovators like Pixium Vision, which is developing a second-generation bionic vision restoration system, there are many bases to cover as the technology is shepherded through development, into trials, and some years later, into reimbursed use.
Positive news flow is a vital component for future funding, confidence building and convincing clinicians, so the French Euronext-listed company...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?